Prediction of microRNA–disease associations with a Kronecker kernel matrix dimension reduction model

Identifying the associations between human diseases and microRNAs is key to understanding pathogenicity mechanisms and important for uncovering novel prognostic markers. To date, a series of computational approaches have been developed for the prediction of disease–microRNA associations. However, these methods remain difficult to perform satisfactorily for diseases with a few known associated microRNAs. This study introduces a novel computational model, namely, the Kronecker kernel matrix dimension reduction (KMDR) model, for identifying potential microRNA–disease associations. This model combines microRNA space and disease space in a larger microRNA–disease space by using the Kronecker product or the Kronecker sum. The predictive performance of our proposed approach was evaluated and validated based on known association datasets. The experimental results show that KMDR achieves reliable prediction with an average AUC of 0.8320 for 22 complex diseases, which indeed outperforms other competitive methods. Moreover, case studies on kidney cancer, breast cancer, and esophageal cancer further demonstrate the applicability of our method in the identification of new disease–microRNA pairs. The source code of KMDR is freely available at https://github.com/ghli16/KMDR.

[1]  Yufei Huang,et al.  Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.

[2]  Cheng Liang,et al.  A graph regularized non-negative matrix factorization method for identifying microRNA-disease associations , 2018, Bioinform..

[3]  Xing Chen,et al.  RKNNMDA: Ranking-based KNN for MiRNA-Disease Association prediction , 2017, RNA biology.

[4]  Nicholas Bertos,et al.  miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. , 2010, Cell metabolism.

[5]  Yusuke Yamamoto,et al.  An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells , 2011, Molecular Cancer.

[6]  Giancarlo Mauri,et al.  Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition , 2014, PloS one.

[7]  Cheng Liang,et al.  Predicting MicroRNA-Disease Associations Using Network Topological Similarity Based on DeepWalk , 2017, IEEE Access.

[8]  Xia Li,et al.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.

[9]  G. Bhanot,et al.  Identification of a microRNA panel for clear-cell kidney cancer. , 2010, Urology.

[10]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[11]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[12]  Fabian J Theis,et al.  PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes , 2010, Genome Biology.

[13]  Xantha Karp,et al.  Encountering MicroRNAs in Cell Fate Signaling , 2005, Science.

[14]  Peizhang Xu,et al.  MicroRNAs and the regulation of cell death. , 2004, Trends in genetics : TIG.

[15]  George M Yousef,et al.  Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. , 2010, Clinical biochemistry.

[16]  Xing Chen,et al.  DRMDA: deep representations‐based miRNA–disease association prediction , 2017, Journal of cellular and molecular medicine.

[17]  Menglong Li,et al.  A kernel matrix dimension reduction method for predicting drug-target interaction , 2017 .

[18]  Kai Zhang,et al.  miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2. , 2014, Carcinogenesis.

[19]  Xing Chen,et al.  MCMDA: Matrix completion for MiRNA-disease association prediction , 2017, Oncotarget.

[20]  Hisashi Kashima,et al.  Fast and Scalable Algorithms for Semi-supervised Link Prediction on Static and Dynamic Graphs , 2010, ECML/PKDD.

[21]  Qionghai Dai,et al.  WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.

[22]  Cheng Liang,et al.  Collective Prediction of Disease-Associated miRNAs Based on Transduction Learning , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[23]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[24]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[25]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[26]  Rebecca L. Siegel Mph,et al.  Cancer statistics, 2016 , 2016 .

[27]  Di Wu,et al.  miRCancer: a microRNA-cancer association database constructed by text mining on literature , 2013, Bioinform..

[28]  Xing Chen,et al.  MicroRNAs and complex diseases: from experimental results to computational models , 2019, Briefings Bioinform..

[29]  Hans Lehrach,et al.  MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy , 2009, Journal of cellular and molecular medicine.

[30]  Cheng Liang,et al.  Predicting MicroRNA-Disease Associations Using Kronecker Regularized Least Squares Based on Heterogeneous Omics Data , 2017, IEEE Access.

[31]  Xia Li,et al.  Prediction of potential disease-associated microRNAs based on random walk , 2015, Bioinform..

[32]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[33]  E. Miska,et al.  MicroRNA functions in animal development and human disease , 2005, Development.

[34]  N. Lynam‐Lennon,et al.  The roles of microRNA in cancer and apoptosis , 2009, Biological reviews of the Cambridge Philosophical Society.

[35]  Xing Chen,et al.  HAMDA: Hybrid Approach for MiRNA-Disease Association prediction , 2017, J. Biomed. Informatics.

[36]  E. Miska,et al.  How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.

[37]  Xing Chen,et al.  PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction , 2017, PLoS Comput. Biol..

[38]  Yi Pan,et al.  Predicting MicroRNA-Disease Associations Based on Improved MicroRNA and Disease Similarities , 2018, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[39]  Xing Chen,et al.  HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction , 2016, Oncotarget.

[40]  C. Tung,et al.  Decreased microRNA(miR)‐145 and increased miR‐224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis , 2013, Clinical and experimental immunology.

[41]  Zhu-Hong You,et al.  A novel computational model based on super-disease and miRNA for potential miRNA-disease association prediction. , 2017, Molecular bioSystems.

[42]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[43]  Qionghai Dai,et al.  RBMMMDA: predicting multiple types of disease-microRNA associations , 2015, Scientific Reports.